Credit Suisse’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.79M | Buy |
26,904
+2,642
| +11% | +$163K | ﹤0.01% | 1933 |
|
|
2023
Q4 | $1.38M | Sell |
24,262
-183
| -0.7% | -$9.59K | ﹤0.01% | 2129 |
|
|
2023
Q3 | $1.33M | Sell |
24,445
-1,065
| -4% | -$63.1K | ﹤0.01% | 2100 |
|
|
2023
Q2 | $1.72M | Buy |
25,510
+2,624
| +11% | +$160K | ﹤0.01% | 2022 |
|
|
2023
Q1 | $1.18M | Buy |
22,886
+834
| +4% | +$40.5K | ﹤0.01% | 2227 |
|
|
2022
Q4 | $1.01M | Buy |
22,052
+4,811
| +28% | +$225K | ﹤0.01% | 2340 |
|
|
2022
Q3 | $874K | Buy |
17,241
+2,051
| +14% | +$102K | ﹤0.01% | 2425 |
|
|
2022
Q2 | $692K | Sell |
15,190
-856
| -5% | -$38.3K | ﹤0.01% | 2635 |
|
|
2022
Q1 | $745K | Buy |
16,046
+1,952
| +14% | +$87.3K | ﹤0.01% | 2734 |
|
|
2021
Q4 | $709K | Sell |
14,094
-696
| -5% | -$36K | ﹤0.01% | 3577 |
|
|
2021
Q3 | $785K | Sell |
14,790
-1,788
| -11% | -$101K | ﹤0.01% | 3520 |
|
|
2021
Q2 | $1.01M | Buy |
16,578
+3,964
| +31% | +$211K | ﹤0.01% | 3376 |
|
|
2021
Q1 | $615K | Sell |
12,614
-5,343
| -30% | -$250K | ﹤0.01% | 3636 |
|
|
2020
Q4 | $727K | Buy |
17,957
+9,608
| +115% | +$343K | ﹤0.01% | 3575 |
|
|
2020
Q3 | $271K | Sell |
8,349
-1,502
| -15% | -$45.1K | ﹤0.01% | 3701 |
|
|
2020
Q2 | $260K | Sell |
9,851
-3,626
| -27% | -$94.8K | ﹤0.01% | 3643 |
|
|
2020
Q1 | $336K | Buy |
13,477
+989
| +8% | +$30.5K | ﹤0.01% | 3352 |
|
|
2019
Q4 | $449K | Sell |
12,488
-987
| -7% | -$34.1K | ﹤0.01% | 3626 |
|
|
2019
Q3 | $460K | Buy |
13,475
+3,102
| +30% | +$99.1K | ﹤0.01% | 3486 |
|
|
2019
Q2 | $289K | Sell |
10,373
-5,355
| -34% | -$149K | ﹤0.01% | 3696 |
|
|
2019
Q1 | $487K | Buy |
15,728
+2,818
| +22% | +$75.2K | ﹤0.01% | 3346 |
|
|
2018
Q4 | $306K | Sell |
12,910
-4,020
| -24% | -$110K | ﹤0.01% | 3508 |
|
|
2018
Q3 | $656K | Sell |
16,930
-5,970
| -26% | -$215K | ﹤0.01% | 3139 |
|
|
2018
Q2 | $767K | Buy |
22,900
+1,777
| +8% | +$63.2K | ﹤0.01% | 3197 |
|
|
2018
Q1 | $765K | Buy |
21,123
+4,588
| +28% | +$159K | ﹤0.01% | 3138 |
|
|
2017
Q4 | $527K | Sell |
16,535
-3,718
| -18% | -$127K | ﹤0.01% | 3412 |
|
|
2017
Q3 | $758K | Buy |
20,253
+11,587
| +134% | +$394K | ﹤0.01% | 3289 |
|
|
2017
Q2 | $270K | Sell |
8,666
-3,772
| -30% | -$109K | ﹤0.01% | 3514 |
|
|
2017
Q1 | $306K | Sell |
12,438
-13,271
| -52% | -$312K | ﹤0.01% | 3508 |
|
|
2016
Q4 | $651K | Sell |
25,709
-5,137
| -17% | -$114K | ﹤0.01% | 3306 |
|
|
2016
Q3 | $612K | Sell |
30,846
-5,995
| -16% | -$105K | ﹤0.01% | 3306 |
|
|
2016
Q2 | $526K | Buy |
+36,841
| New | +$563K | ﹤0.01% | 3391 |
|
Other funds holding LMAT
CCA
CCM
GCM
RIM
CAM
Credit Suisse's LMAT Position: Q1 2024 in Review
Credit Suisse increased its LeMaitre Vascular (LMAT) stake by 11% in Q1 2024, buying an estimated $163K and bringing the position to 26,904 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1933.
Credit Suisse first reported a position in LMAT in Q2 2016 and has held it in 32 quarters since. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.
- Credit Suisse held 26,904 shares of LeMaitre Vascular worth $1.79M as of Q1 2024.
- Credit Suisse bought 2,642 LeMaitre Vascular shares in Q1 2024, an estimated $163K.
- LeMaitre Vascular made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1933 holding.
- Credit Suisse first reported a position in LeMaitre Vascular in Q2 2016 and has held it in 32 quarters since.
- 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.